Arcadia Biosciences, Inc. (RKDA) stock
RKDANasdaqBeveragesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.02 (-11.19%)
Close on Nov 16, 2026Market cap $466.42KP/E –Yield –
Arcadia Biosciences operating margin
Operating margin is operating income as a percentage of revenue.
Arcadia Biosciences's operating margin for the twelve months ending Jun 30, 2026 was -80.1%. For fiscal 2025 it was -51.5%, against -72.3% the year before. The highest annual figure on record is -51.5% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -51.5% | +20.8 |
| FY2024 | Dec 31, 2024 | -72.3% | +64.7 |
| FY2023 | Dec 31, 2023 | -137.0% | +51.8 |
| FY2022 | Dec 31, 2022 | -188.8% | +335.2 |
| FY2021 | Dec 31, 2021 | -524.0% | −364.9 |
| FY2020 | Dec 31, 2020 | -159.0% | +1498.9 |
| FY2019 | Dec 31, 2019 | -1657.9% | −505.6 |
| FY2018 | Dec 31, 2018 | -1152.3% | −796.8 |
| FY2017 | Dec 31, 2017 | -355.6% | +228.5 |
| FY2016 | Dec 31, 2016 | -584.1% | −296.6 |
| FY2015 | Dec 31, 2015 | -287.5% | −70.4 |
| FY2014 | Dec 31, 2014 | -217.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -34.4% | +0.1 |
| Q1 FY2026 | Mar 31, 2026 | -70.8% | −115.0 |
| Q4 FY2025 | Dec 31, 2025 | -152.6% | +34.8 |
| Q3 FY2025 | Sep 30, 2025 | -88.5% | +26.0 |
| Q2 FY2025 | Jun 30, 2025 | -34.4% | −186.0 |
| Q1 FY2025 | Mar 31, 2025 | 44.2% | +205.1 |
| Q4 FY2024 | Dec 31, 2024 | -187.4% | −33.9 |
| Q3 FY2024 | Sep 30, 2024 | -114.5% | −6.9 |
| Q2 FY2024 | Jun 30, 2024 | 151.6% | +263.7 |
| Q1 FY2024 | Mar 31, 2024 | -160.9% | +153.0 |
| Q4 FY2023 | Dec 31, 2023 | -153.5% | +472.5 |
| Q3 FY2023 | Sep 30, 2023 | -107.6% | +146.6 |
| Q2 FY2023 | Jun 30, 2023 | -112.1% | −14.0 |
| Q1 FY2023 | Mar 31, 2023 | -313.9% | −170.3 |
| Q4 FY2022 | Dec 31, 2022 | -626.1% | +9.8 |
| Q3 FY2022 | Sep 30, 2022 | -254.2% | +112.5 |
| Q2 FY2022 | Jun 30, 2022 | -98.1% | +448.7 |
| Q1 FY2022 | Mar 31, 2022 | -143.6% | +499.7 |
| Q4 FY2021 | Dec 31, 2021 | -635.8% | −740.6 |
| Q3 FY2021 | Sep 30, 2021 | -366.7% | +2047.6 |
| Q2 FY2021 | Jun 30, 2021 | -546.8% | +1900.2 |
| Q1 FY2021 | Mar 31, 2021 | -643.2% | +1230.5 |
| Q4 FY2020 | Dec 31, 2020 | 104.8% | +1063.6 |
| Q3 FY2020 | Sep 30, 2020 | -2414.3% | −834.5 |
| Q2 FY2020 | Jun 30, 2020 | -2447.0% | +7.2 |
| Q1 FY2020 | Mar 31, 2020 | -1873.8% | +795.8 |
| Q4 FY2019 | Dec 31, 2019 | -958.9% | +21.7 |
| Q3 FY2019 | Sep 30, 2019 | -1579.8% | −472.0 |
| Q2 FY2019 | Jun 30, 2019 | -2454.2% | −1404.2 |
| Q1 FY2019 | Mar 31, 2019 | -2669.6% | −875.7 |
| Q4 FY2018 | Dec 31, 2018 | -980.6% | −770.5 |
| Q3 FY2018 | Sep 30, 2018 | -1107.8% | −494.1 |
| Q2 FY2018 | Jun 30, 2018 | -1050.0% | −672.9 |
| Q1 FY2018 | Mar 31, 2018 | -1793.9% | −1404.6 |
| Q4 FY2017 | Dec 31, 2017 | -210.1% | +803.1 |
| Q3 FY2017 | Sep 30, 2017 | -613.8% | −248.4 |
| Q2 FY2017 | Jun 30, 2017 | -377.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -389.3% | – |
| Q4 FY2016 | Dec 31, 2016 | -1013.1% | – |
| Q3 FY2016 | Sep 30, 2016 | -365.3% | – |
See a number that looks wrong?